414
Participants
Start Date
July 7, 2014
Primary Completion Date
August 19, 2015
Study Completion Date
February 12, 2018
Galcanezumab
Administered SQ
Placebo
Administered SQ
Island Neuro Associates,PC, Plainview
Rochester Clinical Research, Inc., Rochester
Thomas Jefferson University, Philadelphia
PharmaSite Research Inc, Baltimore
PMG Research of Winston-Salem, LLC, Winston-Salem
PharmQuest, Greensboro
Coastal Carolina Research Center, Inc., Mt. Pleasant
Avail Clinical Research LLC, DeLand
Florida Clinical Research Center LLC, Maitland
Psychiatric Inst of Florida-Clinical Neuroscience Solutions, Orlando
Premiere Research Institute at Palm Beach Neurology, West Palm Beach
Renstar Medical Research, Ocala
CNS Health Care, Memphis
Otri-Med Corporation, Edgewood
Michigan Head, Pain and Neurological Institute, Ann Arbor
Westside Family Medical Center, Kalamazoo
Dean Foundation for Health Research and Education, Middleton
Mercy Health Research, St Louis
ClinVest, Springfield
FutureSearch Trials, Austin
DermResearch, Austin
Alpine Clinical Research Center, Boulder
21st Century Neurology, Phoenix
Arizona Research Center, Phoenix
Clinical Research Advantage, Gilbert
Albuquerque Clinical Trials, Albuquerque
California Medical Clinic for Headache, Santa Monica
Pharmacology Research Institute, Long Beach, Los Alamitos
Collaborative Neuroscience Network - CNS, Long Beach
Pharmacology Research Institute, Long Beach, Encino
Artemis Institute for Clinical Research, San Diego
Medical Center for Clinical Research, San Diego
Desert Valley Research, Rancho Mirage
Pharmacology Research Institute, Long Beach, Newport Beach
San Francisco Clinical Research Center, San Francisco
Summit Research Network Inc, Portland
Northwest Clinical Research Center, Bellevue
North Seattle Womens Group, Seattle
New England Institute for Clinical Research, Stamford
Boston Clinical Trials Inc, Boston
Eli Lilly and Company
INDUSTRY